|
SILK
|
Silk Road Medical, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
SGRY
|
Surgery Partners, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
RVNC
|
Revance Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
0.03%
|
US
|
NASDAQ
|
|
PCRX
|
Pacira Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
MDRX
|
Allscripts Healthcare Solutions, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
KRYS
|
Krystal Biotech, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
0.03%
|
US
|
NASDAQ
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
CORT
|
Corcept Therapeutics Incorporated
|
0.03%
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
CERT
|
Certara, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ATRC
|
AtriCure, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ADUS
|
Addus HomeCare Corporation
|
0.03%
|
US
|
NASDAQ
|
|
VIR
|
Vir Biotechnology, Inc.
|
0.03%
|
US
|
NASDAQ
|